An HPB Commemoration: Leslie H. Blumgart, MD Memorial Tribute; Nancy E. Kemeny, MD Celebratory Symposium; Pancreas Cancer Center Progress Update

The past several years have seen marked improvements in the management of patients with HPB malignancy, which has led to better outcomes and longer survival. The Memorial Sloan Kettering Cancer Center HPB Commemoration consists of three parts:

(1) A memorial Symposium to Leslie H. Blumgart for his many contributions to HPB surgery
(2) A Symposium to celebrate the career of Nancy E. Kemeny and her life’s work treating metastatic liver cancer
(3) An update of advances from the David M. Rubenstein Center for Pancreatic Cancer Research

While the contributions of many individual investigators have played a role, two towering figures stand out for their significant and far-reaching work that has fundamentally changed practice in many ways. The first two days of this event celebrate the careers and many contributions of Dr. Leslie Blumgart, who sadly passed away in September 2022, and Dr. Nancy Kemeny, who will leave the practice of oncology later this year.

Thursday, November 30
The Leslie H. Blumgart, MD Memorial Symposium

Leslie H. Blumgart, MD was an internationally renowned surgeon, one of a small group of pioneering investigators who established the foundation for safe and effective hepatic resection. His work helped transform hepatic resection from a high-risk and highly morbid procedure to a routine operation that is now performed widely for many indications. This change, a major factor in the improved outcome for many patients with primary and metastatic liver cancer, has benefited tens of thousands of patients over the years.

The Leslie H. Blumgart, MD Memorial Symposium brings together friends, colleagues, and former trainees in a tribute to one of the great leaders in academic surgery. The program celebrates his life and how his immense contributions impacted the field of HPB surgery - and also his personal influence on the careers of many of us. This symposium will conclude with a Networking Reception from 5:30-7:00 pm.

Friday, December 1
Nancy E. Kemeny, MD Celebratory Symposium

Nancy E. Kemeny, MD has devoted her career to the treatment of patients with metastatic colorectal cancer and has almost single-handedly established a critical role for regional intrahepatic (HAI) chemotherapy, both in the adjuvant and advanced setting. This therapy was initially not widely accepted outside of MSK, but its efficacy has since been demonstrated and it is now used widely throughout North America and beyond. Its role in other diseases, specifically intrahepatic cholangiocarcinoma, is under active investigation.

The Nancy E. Kemeny, MD Celebratory Symposium will begin with a keynote presentation by Dr. Kemeny on the history and present use of locoregional therapy for liver metastases. The program will consist of state-of-the-art didactic sessions and case presentations on the biology of liver metastases, rationale and types of locoregional approaches as well as the future of HAI therapy. This symposium will conclude with a Networking Reception from 4:30-5:30 pm.

Saturday, December 2
Pancreas Cancer Progress Update

The HPB Commemoration concludes with a half-day Symposium, which will provide an update on research advances from the David M. Rubenstein Center for Pancreatic Cancer Research and showcases the state-of-the-science in pancreas adenocarcinoma.

The program will begin with the David M. Rubenstein Award Lecture, presented by Andrew M. Lowy, MD, FACS of University of California San Diego. Following this lecture, faculty will showcase current and novel therapeutic approaches in this disease with a vision to the future.

Who Should Attend

The target audience for this Symposium includes medical and surgical oncologists, gastroenterologists, internal medicine specialists, pathologists, geneticists, pharmacists, supportive care staff, advanced practice practitioners, nurses, trainees, and other disciplines. MSK is also pleased to invite patients and families to attend on a complimentary basis. Please see registration details below.

Symposium Location

This three-day event will be held in-person only on the campus of Memorial Sloan Kettering, located on the Upper East Side of Manhattan.

Mortimer B. Zuckerman Research Center
417 East 68th Street
New York NY 10065
Get Directions

Online Syllabus

1. Summarize the evolving role of liver resection for managing hepatic malignancy
2. Discuss the role of regional chemotherapy in the management of metastatic and primary liver cancer
3. Implement recent advances in pancreatic cancer research

Program registration includes continental breakfast, lunch, refreshment breaks, and an invitation to the Networking Reception on Thursday evening. Please contact [email protected] at least one week prior to the Symposium if you have any special dietary requests or require any specific accommodations. 

Registration Fees

All 3 Days (Thursday-Saturday, Nov. 30-Dec. 2, 2023)

• Physicians (MDs, PhDs, and DOs): $350
• Advanced Practice Providers: $250
• Pharmacists, Nurses, and Other Healthcare Providers: $175
• Fellows, Residents, and Patients/Families: complimentary*
• Industry Professionals: $625**

Thursday Only — Blumgart Memorial Symposium 

• Physicians (MDs, PhDs, and DOs): $100
• Advanced Practice Providers: $75 (non-refundable)
• Pharmacists, Nurses, and Other Healthcare Providers: $50 (non-refundable)
• Fellows, Residents, MSK Employees, and Patients/Families: complimentary*
• Industry Professionals: $175**

Friday Only — Kemeny Celebratory Symposium

• Physicians (MDs, PhDs, and DOs): $175
• Advanced Practice Providers: $125 (non-refundable)
• Pharmacists, Nurses, and Other Healthcare Providers: $100 (non-refundable)
• Fellows, Residents, MSK Employees, and Patients/Families: complimentary*
• Industry Professionals: $300**

Saturday Only — Pancreas Cancer Progress Update

• Physicians (MDs, PhDs, and DOs): $100
• Advanced Practice Providers: $75 (non-refundable)
• Pharmacists, Nurses, and Other Healthcare Providers: $100 (non-refundable)
• Fellows, Residents, MSK Employees, and Patients/Families: complimentary*
• Industry Professionals: $175**

**Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services are strictly prohibited at MSK CME activities. Please visit our Help page for more information.

Cancellation Policy

If you wish to cancel your participation in this Symposium, you must email [email protected] at least seven (7) days prior to the start of the Symposium, and your refund will be subject to a $25 administrative fee if attending virtually or a $100 administrative fee if attending in-person. Cancellations or no-shows within seven (7) days of the Symposium are not eligible for a refund. Please note that if it has been more than 120 days since payment was processed, a W9 form must be submitted in order process your refund and your refund will be issued in the form of a check payment. Refunds are not subject to tax. You may substitute another registrant in your place at any time by contacting [email protected] with the appropriate information.

MSK CME reserves the right to cancel or postpone any Symposium due to unforeseen circumstances. In the unlikely event we must cancel or postpone this Symposium, you will be notified via email from MSK CME ([email protected]). A full refund will be issued for your registration. MSK CME is not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies.

Please note that the APP, Pharmacists, Nurses, and Other Healthcare Providers rates for individual days are non-refundable. This excludes registration for all three days.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 16.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC/CC Recognition Statements

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

• 16.50 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program; and
• 16.50 CME and Self-Assessment requirements of the American Board of Surgery’s (ABS) Continuous Certification program

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM and ABS MOC/CC credit.

ANCC CNE Statement*

Memorial Sloan Kettering Cancer Center–Nursing Professional Development / Continuing Education is accredited with distinction as a provider of nursing continuing professional development (NCPD) by the American Nurses Credentialing Center’s Commission on Accreditation.

11.75 contact hours will be awarded to participants who attend the program in its entirety and complete a program evaluation. Partial credit not awarded.

*Please note that day 1, the Leslie H. Blumgart, MD Memorial Symposium, is not accredited for Nursing Contact Hours.

Hotel Accommodations

We look forward to welcoming you to Memorial Sloan Kettering for this program. If you’ll be traveling to New York City from out of town, we recommend that you plan your overnight stays as soon as possible. To make the planning a little easier, Memorial Sloan Kettering has negotiated special rates and amenities at select hotels in Manhattan. To view the list of select hotels and additional details on each, please visit: msk.org/accommodations

Parking Information

Street parking in Manhattan is extremely limited, so you may find it more convenient to park in Memorial Sloan Kettering’s garage or in a commercial garage. For a list of parking resources around MSK, click here. Please note that MSK CME does not offer parking validation for Symposium attendees.

MSK Symposium Directors 

William R. Jarnagin, MD, FACS
Leslie Blumgart Chair in Surgery
Chief, Hepatopancreatobiliary Service
Department of Surgery 

Andrea Cercek, MD
Section Head, Colorectal Cancer
Co-Director, Center for Young Onset Colorectal and Gastrointestinal Cancers
Associate Attending
Gastrointestinal Oncology Service
Department of Medicine

Michael I. D'Angelica, MD, FACS
Attending 
Hepatopancreatobiliary Service
Department of Surgery 

Christine A. Iacobuzio-Donahue, MD, PhD
Director, David M. Rubenstein Center for Pancreatic Cancer Research
Attending
Department of Pathology

Yelena Y. Janjigian, MD
Chief, Gastrointestinal Oncology Service
Department of Medicine

T. Peter Kingham, MD, FACS
Director, Global Cancer Disparities Initiatives
Attending
Hepatopancreatobiliary Service
Department of Surgery 

Eileen M. O’Reilly, MD
Winthrop Rockefeller Endowed Chair in Medical Oncology
Section Head, Hepatopancreaticobiliary and Neuroendocrine Cancers
Co-Director of Medical Initiatives, David M. Rubenstein Center for Pancreatic Cancer
Attending, Member
Department of Medicine 
Professor of Medicine, Weill Cornell Medical College

Invited Faculty

Jacques Belghiti, MD, PhD
Emerite Professor
Assistance Publique – Hôpitaux de Paris
Paris, France

Karen Brown, MD
Clinical Professor
Interventional Radiology Service
Weil Cornell Medical College
New York, NY

William Chapman, MD, FACS
Chief of General Surgery
Chief of Section of Abdominal Transplant
Washington University in St. Louis
St. Louis, MO

Bryan Clary, MD, MBA
Professor and Chair of Surgery
Surgeon-in-Chief
University of California, San Diego
La Jolla, CA

Carlos Corvera, MD
Professor of Surgery
Chief, Liver, Biliary, and Pancreatic Surgery
University of California, San Francisco
San Francisco, CA

Ronald DeMatteo, MD
John Rhea Barton Professor and Chair
Endocrine and Oncologic Surgery
University of Pennsylvania 
Philadelphia, PA

Yuman Fong, MD
Chair and Professor
Sangiacomo Family Chair in Surgical Oncology 
City of Hope 
Duarte, CA

Sepideh Gholami, MD, MAS, FACS, FSSO
Director, Liver Multi-Disciplinary Clinic & Hepatic Artery Infusion Program
Director, Translational Research in Surgical Oncology
Northwell Health 
Lake Success, NY

Bas Groot Koerkamp, MD, PhD
Professor of Surgery
Epidemiologist
HPB and Transplant Division
Erasmus University Medical Center 
Rotterdam, South-Holland, The Netherlands

Jonathan Hernandez, MD
Chief, Surgical Oncology Section
Associate Professor of Surgery 
National Cancer Institute (NCI) / National Institutes of Health (NIH)
Bethesda, MD

David Klimstra, MD
Chief Medical Officer 
Paige AI 
New York, NY

Jonathan Koea, MD
Professor of Surgery
Chief HPB/Upper Gastrointestinal Unit
University of Auckland 
Auckland, New Zealand

Michael Lidsky, MD
Associate Professor
Surgical Oncology Service 
Duke Health 
Durham, NC

David Linehan, MD
Professor and Chair
Department of Surgery
University of Rochester 
Rochester, NY

Andrew Lowy, MD
Professor of Surgery
Levine Family Chancellor’s Endowed Chair in Surgical Oncology 
Chief, Division of Surgical Oncology
Associate Clinical Director, Surgery
Moores Cancer Center, University of California, San Diego 
La Jolla, CA

Shishir Maithel, MD
Professor of Surgery
Winship Cancer Institute
Emory University
Atlanta, GA

Richard Schulick, MD, MBA
Director of Cancer Center
Chair of the Department of Surgery
University of Colorado School of Medicine
Aurora, CO

Jean Nicolas Vauthey, MD
Professor of Surgery
MD Anderson Cancer Center 
Houston, TX

MSK Faculty 

Vinod P. Balachandran, MD 
Assistant Attending
Hepatopancreatobiliary Service
Department of Surgery
Assistant Member, Human Oncology and Pathogenesis Program

Olca Basturk, MD
Attending 
Gastrointestinal and Pancreatobiliary Pathology
Department of Pathology and Laboratory Medicine

Christina Bilsky, RN, BSN
Retired Registered Nurse
Hepatopancreatobiliary Service
Department of Surgery 

Alex Blair, MD
Fellow
Hepatopancreatobiliary Service
Department of Surgery

Louise Catherine Connell, MB, BCH, BAO, BMedSc
Assistant Attending 
Gastrointestinal Oncology Service
Department of Medicine 

Andrea Cercek, MD
Section Head, Colorectal Cancer
Co-Director, Center for Young Onset Colorectal and Gastrointestinal Cancers
Associate Attending
Gastrointestinal Oncology Service
Department of Medicine

Christopher Crane, MD
Attending
Department of Radiation Oncology

Michael I. D'Angelica, MD, FACS
Attending 
Hepatopancreatobiliary Service
Department of Surgery 

Richard Kinh Gian Do, MD, PhD
Attending
Body Imaging Service 
Department of Radiology
Professor of Radiology, Weill Cornell Medical College

Jeffrey Drebin, MD, PhD
Chair, Department of Surgery
Acting Hospital President
Murray F. Brennan Chair in Surgery

Mengmeng (Margaret) Du, ScD, MSc
Associate Attending
Department of Epidemiology & Biostatistics

Cristy Fitzpatrick, BSN, MA
Advanced Practice Provider 
Hepatopancreatobiliary Service

Jennifer Flood-Caldwell, MSN, RN, ANP-BC 
Advanced Practice Provider 
Hepatopancreatobiliary Service

Karuna Ganesh, MD, PhD
Assistant Member, Assistant Attending
Molecular Pharmacology Program and Gastrointestinal Oncology Service

James J. Harding, MD
Assistant Attending
Gastrointestinal Oncology and Early Drug Development Service
Department of Medicine 
Assistant Professor of Medicine, Weill Cornell Medical College

Nancy Heffernan, RN, BSN
Registered Nurse
Patient Access

Christine A. Iacobuzio-Donahue, MD, PhD
Director, David M. Rubenstein Center for Pancreatic Cancer Research
Attending
Department of Pathology

Yelena Y. Janjigian, MD
Chief, Gastrointestinal Oncology Service
Department of Medicine

William R. Jarnagin, MD, FACS
Leslie Blumgart Chair in Surgery
Chief, Hepatopancreatobiliary Service
Department of Surgery 

Nancy Kemeny, MD, FACSO
Attending
Gastrointestinal Oncology Service
Department of Medicine
Professor of Medicine, Weill Cornell Medical College

T. Peter Kingham, MD, FACS
Director, Global Cancer Disparities Initiatives
Attending
Hepatopancreatobiliary Service
Department of Surgery 

Marion Liu, MD
Chief Surgical Oncology Fellow
Hepatopancreatobiliary Service
Department of Surgery 

Helen Loumeau, MA, ANP-BC
Advanced Practice Provider 
Hepatopancreatobiliary Service

Eileen M. O’Reilly, MD
Winthrop Rockefeller Endowed Chair in Medical Oncology
Section Head, Hepatopancreaticobiliary and Neuroendocrine Cancers
Co-Director of Medical Initiatives, David M. Rubenstein Center for Pancreatic Cancer
Attending, Member
Department of Medicine 
Professor of Medicine, Weill Cornell Medical College

Wungki Park, MD, MS
Assistant Attending
Gastrointestinal Oncology Service 
Department of Medicine
Assistant Professor, Weill Cornell Medical College

Philip B. Paty, MD
Attending Surgeon
Talcott Chair for Clinical Excellence 
Colorectal Service
Department of Surgery

Devika Rao, MD, FACP
Assistant Attending
Medical Site Director - MSK Basking Ridge
Department of Medicine 

Diane Reidy-Lagunes, MD
Associate Attending, Vice Chair 
Gastrointestinal Oncology Service
Department of Medicine

Mark A. Schattner, MD, FASGE, AGAF
Chief, Gastroenterology, Hepatology 
and Nutrition Service 
Professor of Clinical Medicine, Weill Cornell College of Medicine 

Joshua Schoenfeld, MD, PhD
Medical Oncology Fellow
Gastrointestinal Oncology Service 
Department of Medicine

Lawrence H. Schwartz, MD
Chair, Department of Radiology

Neil H. Segal, MD, PhD
Associate Attending
Research Director
Gastrointestinal Oncology Service 
Department of Medicine

Kevin C. Soares, MD, MSc
Assistant Attending
Hepatopancreatobiliary Service 
Department of Surgery

Constantinos T. Sofocleous, MD, PhD
Attending
Interventional Radiology 
Department of Radiology
Professor of Radiology, Weill Cornell College of Medicine 

Selwyn M. Vickers, MD, FACS
President and CEO

Alice Wei, MD, MSc, FRCSC, FACS
Attending Surgeon
Hepatopancreatobiliary Service 
Department of Surgery 
Associate Professor of Surgery, 
Weill-Cornell School of Medicine

Rona Yaeger, MD
Associate Attending
Gastrointestinal Oncology Service 
Department of Medicine

Kenneth H. Yu, MD, MSc
Associate Member
Gastrointestinal Oncology Service 
Department of Medicine

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.

Memorial Sloan Kettering gratefully acknowledges the following organizations for providing educational grants for this live activity:

• Intera Oncology
• Ipsen Biopharmaceuticals, Inc.
• Olympus Corporation of the Americas